JP2011507929A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507929A5 JP2011507929A5 JP2010540098A JP2010540098A JP2011507929A5 JP 2011507929 A5 JP2011507929 A5 JP 2011507929A5 JP 2010540098 A JP2010540098 A JP 2010540098A JP 2010540098 A JP2010540098 A JP 2010540098A JP 2011507929 A5 JP2011507929 A5 JP 2011507929A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- same
- different
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 32
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 32
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 20
- 125000005843 halogen group Chemical group 0.000 claims 19
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 18
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 claims 17
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 17
- 125000001424 substituent group Chemical group 0.000 claims 17
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 14
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 13
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 12
- 238000000034 method Methods 0.000 claims 11
- 125000003277 amino group Chemical group 0.000 claims 10
- 239000000460 chlorine Substances 0.000 claims 10
- 229910052794 bromium Inorganic materials 0.000 claims 9
- 229910052801 chlorine Inorganic materials 0.000 claims 9
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 9
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 8
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 8
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 7
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 6
- 125000001246 bromo group Chemical group Br* 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims 5
- 125000001153 fluoro group Chemical group F* 0.000 claims 5
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- 239000011347 resin Substances 0.000 claims 3
- 229920005989 resin Polymers 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 238000003776 cleavage reaction Methods 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- 230000007017 scission Effects 0.000 claims 2
- -1 CF 3 group Inorganic materials 0.000 claims 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 claims 1
- 239000007822 coupling agent Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000005414 inactive ingredient Substances 0.000 claims 1
- 150000002475 indoles Chemical class 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- RCHKEJKUUXXBSM-UHFFFAOYSA-N n-benzyl-2-(3-formylindol-1-yl)acetamide Chemical compound C12=CC=CC=C2C(C=O)=CN1CC(=O)NCC1=CC=CC=C1 RCHKEJKUUXXBSM-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07425830A EP2078711A1 (en) | 2007-12-28 | 2007-12-28 | (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| EP07425830.2 | 2007-12-28 | ||
| PCT/EP2008/067622 WO2009083436A1 (en) | 2007-12-28 | 2008-12-16 | (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011507929A JP2011507929A (ja) | 2011-03-10 |
| JP2011507929A5 true JP2011507929A5 (enExample) | 2014-01-23 |
| JP5698985B2 JP5698985B2 (ja) | 2015-04-08 |
Family
ID=39167787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010540098A Expired - Fee Related JP5698985B2 (ja) | 2007-12-28 | 2008-12-16 | ５位置換アザインドール誘導体，それを含む医薬組成物，中間化合物及びその製造方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8399477B2 (enExample) |
| EP (3) | EP2078711A1 (enExample) |
| JP (1) | JP5698985B2 (enExample) |
| KR (2) | KR101671874B1 (enExample) |
| CN (1) | CN101910127B (enExample) |
| AR (1) | AR069961A1 (enExample) |
| AU (1) | AU2008342705B2 (enExample) |
| BR (1) | BRPI0821450A2 (enExample) |
| CA (1) | CA2707339C (enExample) |
| DK (2) | DK2234968T3 (enExample) |
| EA (1) | EA020373B1 (enExample) |
| ES (2) | ES2523167T3 (enExample) |
| GE (1) | GEP20125547B (enExample) |
| IL (1) | IL206062A (enExample) |
| PL (2) | PL2234968T3 (enExample) |
| PT (2) | PT2444392E (enExample) |
| SG (1) | SG187400A1 (enExample) |
| SI (2) | SI2234968T1 (enExample) |
| UA (1) | UA100867C2 (enExample) |
| WO (1) | WO2009083436A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101365824B1 (ko) | 2010-10-22 | 2014-02-20 | 엘지디스플레이 주식회사 | 유기전계발광소자 |
| RS59007B1 (sr) | 2014-02-03 | 2019-08-30 | Vitae Pharmaceuticals Llc | Dihidropirolopiridinski inhibitori ror-gama |
| RU2681537C2 (ru) * | 2014-04-14 | 2019-03-07 | Шанхай Хэнжуй Фармасьютикал Ко., Лтд. | Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение |
| US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| WO2017024018A1 (en) * | 2015-08-05 | 2017-02-09 | Vitae Pharmaceuticals, Inc. | Modulators of ror-gamma |
| KR20180086221A (ko) | 2015-11-20 | 2018-07-30 | 비타이 파마슈티컬즈, 인코포레이티드 | Ror-감마의 조절물질 |
| TW202220968A (zh) | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| CN107033026A (zh) * | 2017-06-07 | 2017-08-11 | 李博强 | 一种对硝基苯肼盐酸盐的制备方法 |
| WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF ROR GAMMA |
| MA49685A (fr) | 2017-07-24 | 2021-04-14 | Vitae Pharmaceuticals Llc | INHIBITEURS DE ROR gamma |
| CN114302874B (zh) * | 2019-08-26 | 2025-02-25 | 国际药品株式会社 | 吲哚甲酰胺衍生物和包含吲哚甲酰胺衍生物的药物组合物 |
| CN114605303A (zh) * | 2022-03-14 | 2022-06-10 | 武汉工程大学 | 一种地拉韦啶及其中间体的合成方法 |
| CN119019389A (zh) * | 2024-06-05 | 2024-11-26 | 四川大学 | 7-氮杂吲哚类化合物及其合成方法和用途 |
| CN119101040B (zh) * | 2024-11-08 | 2025-03-21 | 杭州澳赛诺医药技术有限公司 | 一种通过去对称化合成芳基取代的手性四氢吡喃环的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2354766A1 (fr) | 1976-06-17 | 1978-01-13 | Labaz | Derives n-aminoalkyles d'indole et procedes pour les preparer |
| US6114532A (en) * | 1998-02-03 | 2000-09-05 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals |
| CA2319494A1 (en) * | 1998-02-03 | 1999-08-12 | Boehringer Ingelheim Pharma Kg | 5-membered heterocyclic condensed benzoderivatives, the preparation thereof and their use as pharmaceuticals |
| DE19834751A1 (de) * | 1998-08-01 | 2000-02-03 | Boehringer Ingelheim Pharma | Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel |
| CA2402516A1 (en) * | 2000-03-20 | 2001-09-27 | Roopa Rai | Non-amidine containing protease inhibitors |
| US20020052373A1 (en) * | 2000-10-26 | 2002-05-02 | Zorn Stevin H. | Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease |
| IL140096A0 (en) * | 2000-12-05 | 2002-02-10 | Internat Specialty Products Is | Process for preparation of zafirlukast |
| DE10147672A1 (de) * | 2001-09-27 | 2003-04-10 | Bayer Ag | Substituierte 2,5-Diamidoindole und ihre Verwendung |
| AU2003303217A1 (en) * | 2002-12-20 | 2004-07-14 | Bayer Healthcare Ag | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| SE0300908D0 (sv) * | 2003-03-31 | 2003-03-31 | Astrazeneca Ab | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them |
| CA2589779A1 (en) * | 2004-12-23 | 2006-06-29 | F. Hoffmann-La Roche Ag | Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors |
| WO2007042816A1 (en) * | 2005-10-12 | 2007-04-19 | Biolipox Ab | Benzoxazoles useful in the treatment of inflammation |
| MX2008012945A (es) * | 2006-04-07 | 2009-01-15 | Vertex Pharma | Moduladores de transportadores de cartucho de union a adenosina-trifosfato celular (atp). |
| JP2008006663A (ja) * | 2006-06-28 | 2008-01-17 | Pilot Ink Co Ltd | 出没式筆記具 |
| ITMI20061368A1 (it) * | 2006-07-14 | 2008-01-15 | Acraf | Composto 2-arilindolico sostituito in posizione 5, composizione farmaceutica che lo comprende nonche' composti intermedi e procedimento per prepararlo |
-
2007
- 2007-12-28 EP EP07425830A patent/EP2078711A1/en not_active Withdrawn
-
2008
- 2008-12-16 CN CN2008801227655A patent/CN101910127B/zh not_active Expired - Fee Related
- 2008-12-16 JP JP2010540098A patent/JP5698985B2/ja not_active Expired - Fee Related
- 2008-12-16 KR KR1020107015290A patent/KR101671874B1/ko not_active Expired - Fee Related
- 2008-12-16 DK DK08868725.6T patent/DK2234968T3/da active
- 2008-12-16 EP EP08868725A patent/EP2234968B1/en not_active Not-in-force
- 2008-12-16 BR BRPI0821450-6A patent/BRPI0821450A2/pt not_active IP Right Cessation
- 2008-12-16 WO PCT/EP2008/067622 patent/WO2009083436A1/en not_active Ceased
- 2008-12-16 PL PL08868725T patent/PL2234968T3/pl unknown
- 2008-12-16 EP EP11194457.5A patent/EP2444392B1/en not_active Not-in-force
- 2008-12-16 US US12/745,356 patent/US8399477B2/en not_active Expired - Fee Related
- 2008-12-16 PT PT111944575T patent/PT2444392E/pt unknown
- 2008-12-16 DK DK11194457.5T patent/DK2444392T3/en active
- 2008-12-16 UA UAA201006371A patent/UA100867C2/uk unknown
- 2008-12-16 EA EA201070804A patent/EA020373B1/ru not_active IP Right Cessation
- 2008-12-16 AU AU2008342705A patent/AU2008342705B2/en not_active Ceased
- 2008-12-16 PT PT88687256T patent/PT2234968E/pt unknown
- 2008-12-16 ES ES11194457.5T patent/ES2523167T3/es active Active
- 2008-12-16 ES ES08868725T patent/ES2408955T3/es active Active
- 2008-12-16 PL PL11194457T patent/PL2444392T3/pl unknown
- 2008-12-16 SI SI200830950T patent/SI2234968T1/sl unknown
- 2008-12-16 SI SI200831326T patent/SI2444392T1/sl unknown
- 2008-12-16 KR KR1020167004925A patent/KR20160029861A/ko not_active Ceased
- 2008-12-16 GE GEAP200811899A patent/GEP20125547B/en unknown
- 2008-12-16 SG SG2012095667A patent/SG187400A1/en unknown
- 2008-12-16 CA CA2707339A patent/CA2707339C/en not_active Expired - Fee Related
- 2008-12-23 AR ARP080105698A patent/AR069961A1/es not_active Application Discontinuation
-
2010
- 2010-05-30 IL IL206062A patent/IL206062A/en not_active IP Right Cessation
-
2013
- 2013-02-15 US US13/768,013 patent/US8871948B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507929A5 (enExample) | ||
| WO2008115098A3 (fr) | 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation | |
| JP2004523529A5 (enExample) | ||
| NO20072371L (no) | Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister | |
| JP2007517035A5 (enExample) | ||
| JP2006528621A5 (enExample) | ||
| NO20080738L (no) | Fremgangsmater for neurobeskyttelse | |
| JP2008530099A5 (enExample) | ||
| NZ231631A (en) | Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions | |
| WO2008035381A3 (en) | Process for the preparation of amine derivatives as calcimimetics | |
| NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
| NZ561747A (en) | (Pyrrol-2-ylmethyl)-indol-1-yl-acetic acid derivatives with PGD2 antagonist activity | |
| JP2010540593A5 (enExample) | ||
| MX2008000115A (es) | Derivados de piperidina utiles como antagonistas de histamina h3. | |
| PL164480B1 (pl) | Sposób wytwarzania nowych pochodnych aminofenolu PL | |
| JP2005505618A5 (enExample) | ||
| MX2009003927A (es) | Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes. | |
| WO2008101935A3 (fr) | Nouveaux composés dérivés d'indole et compositions pharmaceutiques les contenant | |
| JP2008546770A5 (enExample) | ||
| JP2009525312A5 (enExample) | ||
| MX2011009700A (es) | Derivado de amida. | |
| WO2007042912A3 (en) | Heterocyclic compounds as pstat3/il-6 inhibitors | |
| JP2006511498A5 (enExample) | ||
| JPH01268679A (ja) | １―シクロプロピル―キノロンカルボン酸及びその誘導体の製造方法 | |
| CZ265994A3 (en) | Derivatives of 1-/2h-1-benzopyran-2-on-8-yl/piperazine, process of their preparation pharmaceutical compositions containing thereof as active components and their use |